Assured efficient with no increased risk of HYPOGLYCEMIA and weight gain with the Sitatri - M tablets
The Universal Promise to Live Well! Sitatri - M 50/500 Tablets
-
CV, Renal and Hepatic Safe
-
Introducing of sitagliptin delays the need of additional drugs
-
30% less likelihood to start long term insulin therapy in the sitagliptin group
-
28% fewer patients recieved additional AHA therapy in the sitagliptin group
-
Additional Anti-hyperglycemia agents, chronic insulin therapt
